Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study
奥德罗内西他单药治疗CAR-T细胞疗法进展后的复发/难治性弥漫性大B细胞淋巴瘤:ELM-1研究的主要分析
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024027044
Topp, Max S; Matasar, Matthew; Allan, John N; Ansell, Stephen M; Barnes, Jeffrey A; Arnason, Jon E; Michot, Jean-Marie; Goldschmidt, Neta; O'Brien, Susan M; Abadi, Uri; Avivi, Irit; Cheng, Yuan; Flink, Dina M; Zhu, Min; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Crombie, Jennifer L